Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study.

Restelli, Umberto; Ceresoli, Giovanni Luca; Croce, Davide; Evangelista, Laura; Maffioli, Lorenzo Stefano; Gianoncelli, Letizia; Bombardieri, Emilio

Restelli, Umberto; Ceresoli, Giovanni Luca; Croce, Davide; Evangelista, Laura; Maffioli, Lorenzo Stefano; Gianoncelli, Letizia; Bombardieri, Emilio.

Afiliación

Restelli U; Center for Health Economics, Social and Health Care Management, LIUC - Università Cattaneo, Castellanza, Italy.
Ceresoli GL; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Croce D; Medical Oncology Department, Thoracic and Urologic Oncology Unit, Cliniche Humanitas Gavazzeni, Bergamo.
Evangelista L; Center for Health Economics, Social and Health Care Management, LIUC - Università Cattaneo, Castellanza, Italy.
Maffioli LS; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Gianoncelli L; Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV - IRCCS, Padova.
Bombardieri E; Nuclear Medicine Department, Cancer Centre - ASST Ovest Milanese, Legnano.

Cancer Manag Res ; 9: 789-800, 2017.

Article en En | MEDLINE | ID: mdl-29263702

Palabras clave

Italy; cost analysis; metastatic castrate-resistant prostate cancer; oncology; resource consumption; skeletal related events

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: Cancer Manag Res Año: 2017 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google